NSE filing, NSE: ZOTA. Summary written from the filing by ALFA Finder's alert engine.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,328.80
- Market cap
- ₹4,602 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -40.8×Sector 48.7×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 6.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Earnings Call Transcript: Key Takeaways
Zota reported robust revenue growth driven by Dawaa India, though consolidated PAT remains in loss.
Zota Healthcare Results Update
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
- Key figure
- Net loss ₹26 Cr
Zota Healthcare Price Movement Clarification
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Healthcare Business Update
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
- store expansion
- 20.0 stores
Zota Healthcare Capital Structure Change
Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.
- Value
- ₹2.10 Cr
Other board meeting date announcements
All →Signatureglobal (India) Board Meeting Date
Signatureglobal (India) has scheduled a board meeting on November 5, 2026, to consider unaudited standalone and consolidated results for Q2 and H1 FY2026-27. The trading window stays closed until November 7, 2026.
Mahasagar Travels Board Meeting Date
Mahasagar Travels will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window opened 1 October 2026.
Sansera Engineering Board Meeting Date
Sansera Engineering will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter ended September 30, 2026. The trading window for designated persons has been closed since October 1, 2026.
Contil India Board Meeting Date
Contil India will hold a board meeting on 6 November 2026 to consider unaudited standalone half-yearly results. Trading window closed 1 October to 14 November 2026.
GSB Finance Board Meeting Date
Coffers Finvest will hold a board meeting on 4 November 2026 to approve September quarter results. Trading window stays closed until 48 hours after results.
Liotech Industries Board Meeting Date
Liotech Industries will hold a board meeting on November 4, 2026 to consider standalone unaudited results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results are declared.